Mirror Now
@mirrornow·2.2M subscribers·145K videos
Johnson & Johnson seeks nod for vaccine trial on children in India
Posted
August 20, 2021
Views
706
Likes
6
Comments
1
Engagement
0.99%
August 20, 2021
706
6
1
0.99%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
3:23Now PlayingMultinational pharma giant Johnson & Johnson (J&J) has applied to India's drug regulator, seeking permission to conduct the first clinical trials of its single-shot Covid-19 vaccine Jannsen on children aged 12 to 17 years. The application has been submitted to the Central Drugs Standard Control Organisation (CDSCO). Meanwhile, clinical trials of Bharat Biotech's Covaxin and Zydus Cadila are also underway, and the results are expected to be out by September. Johnson &Johnson is now moving a step closer by requesting DCJI for supplying its first single-shot vaccine to the age group of 12 to 17 years. Watch to know more!
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
